| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.08B | -7.7% |
| Cost of Revenue | $877.5M | -1.3% |
| Gross Profit | $199.7M | -28.0% |
| R&D Expense | $1.5M | +15.4% |
| SG&A Expense | $176.5M | +4.0% |
| Operating Income | -$228.8M | -1169.6% |
| Pre-tax Income | -$411.4M | -214.7% |
| Income Tax | $4.2M | -64.0% |
| Net Income | -$415.6M | -191.9% |
| EPS (Basic) | -$6.86 | -462.3% |
| EPS (Diluted) | -$6.86 | -457.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.1M | -27.4% |
| Accounts Receivable | $101.6M | -44.8% |
| Inventory | $16.8M | +10.7% |
| Current Assets | $190.5M | -31.9% |
| Total Assets | $721.9M | -30.4% |
| Current Liabilities | $510.0M | +2.0% |
| Long-term Debt | $1.10B | -12.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$87.2M | +21.9% |
| Capital Expenditures | $18.3M | +25.6% |
| Investing Cash Flow | -$21.8M | -135.1% |
| Financing Cash Flow | $106.6M | +8.1% |
| Free Cash Flow | -$105.5M | +16.4% |
| Total Liabilities |
| $1.53B |
| -10.2% |
| Stockholders' Equity | -$807.6M | -21.1% |